Skip to main content
SpringerLink
Log in

Was gibt’s Neues in der Urologie?

  • Conference paper
Tagung 14.–17. Oktober 1987, Stuttgart

Part of the book series: Verhandlungsbericht der Deutschen Gesellschaft für Urologie ((VBDGUROLOGIE,volume 39))

  • 17 Accesses

Zusammenfassung

Hauptziele der Tumorimmunologie im letzten Jahrzehnt waren die Identifizierung spezifischer Immunreaktionen mit dem Karzinom und die Entwicklung immunologischer Manipulationen, mit denen die Regression von Tumoren erreicht werden kann.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Hypernephrom: Adoptive Immuntherapie

  1. Belldegrun A, Linehan WM, Robertson CN, Rosenberg SA (1986) Isolation and characterization of lymphocytes infiltrating human renal cell cancer: Possible application for therapeutic adoptive immunotherapy. Surg Forum 37: 671

    Google Scholar 

  2. Belldegrun A, Webb DE, Austin HA III, Steinberg SM, Withe DE, Linehan WM, Rosenberg SA (1987) Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer. Ann Intern Med 106: 817–822

    PubMed  CAS  Google Scholar 

  3. Durant JR (1987) Immunotherapy of cancer–the end of the beginning? N Engl J Med 316 /15: 939–941

    Article  PubMed  CAS  Google Scholar 

  4. Lafreniere R, Rosenberg StA (1985) Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and adenocarcinoma. J Immunol 135 /6: 4273–4280

    PubMed  CAS  Google Scholar 

  5. Rosenberg SA (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485–1492

    Article  PubMed  CAS  Google Scholar 

  6. Rosenberg SA (1986) Adoptive immunotherapy of cancer using lymphokine-activated killer cells and recombinant interleukin-2. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Important advances in oncology. Lippincott, New York, pp 55–91

    Google Scholar 

  7. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan M, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316 /15: 898–905

    Article  Google Scholar 

  8. West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK (1987) Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advance cancer. N Engl J Med 316 /15: 898–905

    Article  PubMed  CAS  Google Scholar 

Hodentumor

  1. Freiha, FS, Shortliffe LD, Picozzi VJ, Torn FM, Alto P (1985) Stage I non-seminomatous testis tumors: is retroperitoneal lymph node dissection always necessary? J Urol 133 (4), Abstr Nr 524: 244 A

    Google Scholar 

  2. Gelderman WA, Schrafford-Koops H, Sleijfer DT, Oosterhuis JW, Marrink J, de Bruijn HW, Oldhoff J (1987) Orchiectomy alone in stage I non-seminomatous testicular germ cell tumors. Cancer 59: 578–580

    Article  PubMed  CAS  Google Scholar 

  3. Jewett MAS, Comiarow RH, Herman JG, Sturgeon JFG, Alison RE, Cospodarowicz MK (1984) Results with orchiectomy only for stage I non-seminomatous testis tumor. J Urol 131, Abstr 483: 244A

    Google Scholar 

  4. Peckham MJ, Brada M (1987) Surveillance following orchiectomy for stage I testicular cancer. Int J Androl 10: 247–254

    Article  PubMed  CAS  Google Scholar 

  5. Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L (1985) Surveillance of lymph node dissection in clinical stage I nonseminomatous germinal testis cancer? Br J Urol 57 /6: 759–762

    Article  PubMed  CAS  Google Scholar 

  6. Poisel S, Colleselli K, Schachtner W, Bartsch G (1987) Nerve preserving bilateral retroperitoneal lymphadenectomy - anatomy and operative approach. J Urol 137: A 441

    Google Scholar 

  7. Rorth M, von der Maase H, Nielsen ES, Pedersen M, Schultz H (1987) Orchiectomy alone vs. orchidectomy plus radiotherapy in stage I non-seminomatous testicular cancer: A randomized study by the Danish testicular carcinoma study group. Int J Androl 10: 225–262

    Google Scholar 

  8. Sogani PC, Whitmore WF, Herr HW, Morse MJ, Bosl G, Fair W (1985) Long term experience with orchiectomy alone in treatment of clinical stage I nonseminomatous germ cell tumor of testis. J Urol 133, Abstr 532: 246A

    Google Scholar 

  9. Swanson D, Johnson D (1985) Orchiectomy alone for clinical stage I nonseminomatous germ cell testicular tumors (NSGCTT): 46 patients with a minimum 12 month follow-up. XX. Kongreß der Intern Gesellschaft für Urologie Wien, Abstr Nr 177: 113

    Google Scholar 

  10. Waegner W, Schmoll HJ, Schwedler T, Schindler E, Kolle P (1984) Management of stage I nonseminomatous testicular cancer (NSGCT) in 104 patients with or without lymphadenectomy. Verh Dtsch Krebs Ges 5. Fischer, Stuttgart New York, p 658

    Google Scholar 

  11. Weissbach L, Boedefeld EA (1987) Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 138: 77–82

    PubMed  CAS  Google Scholar 

Prostatakarzinom-PSA (Prostato spezifisches Antigen)

  1. Allhoff EP, Proppe KH, Chapman CM, Lin C-W, Prout GR Jr (1983) Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol 129: 315–318

    PubMed  CAS  Google Scholar 

  2. Bercovich E, Soli M, Laria G, Plate L (1987) Prostate specific antigen (PSA) in diagnosis and follow-up of prostatic cancer. J Urol 137, Abstr 365: 195A

    Google Scholar 

  3. Ercole CJ, Lange PH (1987) The relative value of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) serum determination in the management of carcinoma of the prostate (CAP). J Urol 137, Abstr 368: 195 A

    Google Scholar 

  4. Ferro MA, Barnes I, Roberts JBM, Smith PJB (1987) Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. Br J Urol 60: 69–73

    Article  PubMed  CAS  Google Scholar 

  5. Fornara P, Sturm W, Fabricius PG, Schmiedt E (1987) Klinische Relevanz der radioimmunologiichen Bestimmung des prostataspezifischen Antigens ( PSA) beim Prostatakarzinom. Urologe (A) 26: 158–161

    CAS  Google Scholar 

  6. Killian CS, Yang N, Emrich LI, Vargas FP, Kuriyama M, Wang MC, Slack NH, Papsidero LD, Murphy GP, Chu TM, and the Investigators of the National Prostatic Cancer Projekt (1985) Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. Cancer Res 45: 886–891

    PubMed  CAS  Google Scholar 

  7. Killian CS, Emrich LJ, Constantine RI, Chu TM (1987) Prostate-specific antigen (PSA) in prostate cancer. J Urol 137, Abstr 366: 195 A

    Google Scholar 

  8. Kuriyama M, Wang MC, Lee CL, Killian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishiura T, Slack NH, Murphy GP, Chu TM (1982) Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. JNC1 68 /1: 99

    CAS  Google Scholar 

  9. Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, Nishiura T, Murphy GP, Chu TM (1980) R. Hautmann: Was gibt’s Neues in der Urologie? Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 40: 4568–4662

    Google Scholar 

  10. Oesterling JE, Bruzek DJ, Chan DW, Epstein JI, Kimball AW Jr, Rock RC, Brendler ChB, Walsh PC (1987) The value of prostatic specific antigen in the management of adenocarcinoma of the prostate. J Urol 137, Abstr 364: 194A

    Google Scholar 

  11. Siddall JK, Cooper EH, Newling DWW, Robinson MRG, Whelan P (1986) An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate. Eur Urol 12: 123–130

    PubMed  CAS  Google Scholar 

  12. Stamey TA, Hay AR, McNeal JE, Freiha FS, Yang N (1987) An evaluation of prostate-specific antigen in the diagnosis and treatment of prostate cancer. J Urol 137, Abstr 367: 195 A

    Google Scholar 

  13. Stone NN, Nisselbaum JS, Stankievic R, Schwartz D, Schwartz MK (1987) Prostatic specific antigen, prostatic acid phosphatase and acid phosphatase in patients with prostate cancer and benign prostatic hyperplasia. J Urol 137, Abstr 356: 192A

    Google Scholar 

  14. Teillac P, Peyret Chr, Leroy M, Rabaud B, Arraco JP, Najean Y, le Duc A (1987) Prostatic specific antigen (PSA) in prostatic pathology. J Urol 137, Abstr 369: 196 A

    Google Scholar 

  15. Wang MC, Valenzuela LA, Murphy GP, Chu TM (1979) Purification of a human prostate specific antigen. Invest Urol 17 /2: 159–163

    PubMed  CAS  Google Scholar 

  16. Wirth M, Grups J, Frohmüller H (1987) Vergleichende Untersuchung des prostataspezifischen Antigens und der prostata-spezifischen sauren Phosphatase in der Diagnostik und Verlaufskontrolle des Prostatakarzinoms. Verhandlb Dtsch Ges Urologie 38: 75

    Google Scholar 

  17. Wirth M, Grups JW, Gomes de Oliveira J, Frohmüller H (1986) Vergleichende Untersuchung des prostataspezifischen Antigens und der prostataspezifischen sauren Phosphatase in der Diagnostik des Prostatakarzinoms. Verhandlb Dtsch Ges Urologie 37: 161–162

    Google Scholar 

Sonographie

  1. Egghart G, Schlickenrieder JHM, Hautmann R (1986) Diagnostik des kindlichen Refluxes mit CO2 und Ultraschall. Urologe (A) 25: 329–332

    CAS  Google Scholar 

  2. Pfister R, Biber RJ, Rose JS (1982) Monitoring ureteral reflux with ultrasound. Urologic Section of the 51th American Academy of Pediatric Meeting, October 6

    Google Scholar 

  3. Schneider K, Jablonski C, Wiesner M, Kohn M, Fendei H (1984) Pediatr Radiol 14: 400

    Article  PubMed  CAS  Google Scholar 

Andrologie

  1. Adams R et al (1960) Gossypol, a pigment of cotton seed. Chem Rev 60: 555

    Article  PubMed  CAS  Google Scholar 

  2. Guo-zhen Liu, Lyle KC, Jian Cao: Trial of gossypol as a male contraceptive. Capital Hospital, The Chinese Academy of Medical Sciences Beijing, The People’s Republic of China

    Google Scholar 

  3. Hadley MA, Young CL, Dym M (1981) Effects of gossypol on the reproductive system of male rats. J Androl 2: 190

    CAS  Google Scholar 

  4. Leyson JFJ (1987) Comparative study between oral and intra-penile vasoactive drugs in the management of impotence in neurogically impaired patients. J Urol 137, Abstr 326: 185 A

    Google Scholar 

  5. Lei Hai Peng (1983) Future prospects of gossypol as a male contra-ceptive. Yi Yao Xue Bao 18: 321

    Google Scholar 

  6. Lue T, Tanagho F, EA (1987) Physiology of erection and pharmacological management of impotence. J Urol 137: 829–836

    Google Scholar 

  7. Marchlewski L (1899) Gossypol, ein Bestandteil der Baumwollsamen. J Prakt Chem 60: 84

    Article  CAS  Google Scholar 

  8. National Coordinating Group on Male Antifertility Agents (1978) Gossypol - a new antifertility agent for males. Chin Med J 4: 417

    Google Scholar 

  9. Witherington R (1987) External aids for treatment of impotence. J Urol Nursing 6 /1

    Google Scholar 

  10. Wu-Jieping (1987) The role of urologists in China’s family planning programm. Academic Program of PTP Urology Delegation, Beijing Seminar on Urology, Function Hall, Kunlun Hotel, Juni 5 to 6

    Google Scholar 

  11. Xue She Pu (1980) Studies on the antifertility effect of gossypol. A new contraceptive for males. Recent Advances in Fertility Regulation, Proc Symp, Beijing Sept

    Google Scholar 

Harnröhrenchirurgie

  1. Chiou RK, Ercole CJ (1987) Endourethroplasty: A useful technique in the management of complicated posterior urethral strictures. J Urol 137/4, Abstr 288: 175A

    Google Scholar 

  2. Huang Ruotong (1987) Endoscopic reestablishment of urethral continuity of obliterated urethra under the guidance of a catheter. Programme for PTP Urology Delegation in Guangzhou, June 10

    Google Scholar 

  3. Marshall FF, Chang R, Gearhart JP (1987) Endoscopic reconstruction of traumatic membranous urethral transection. J Urol 137/4, Abstr 287: 175 A

    Google Scholar 

  4. Schreiter F, Noll F (1987) Meshgraft urethroplasty, World J Urol 5: 41–46

    Article  Google Scholar 

  5. Thüroff JW (1986) Funktionsstörungen des unteren Harntraktes–Anatomie und Physiologie. In: Hohenfellner, Thüroff, Schulte-Wissermann (Hrsg) Kinderurologie in Klinik und Praxis. Thieme, Stuttgart New York, S 400–408

    Google Scholar 

  6. Webster GD (1987) Repair of the difficult posterior urethral stricture. World J Urol 5: 30–36

    Article  Google Scholar 

Genexpression/-deletion

  1. DeWolf WC (1987) Somatic deletion of chromosome 6 DNA in human teratocarcinoma. J Urol 137/4, Abstr 437

    Google Scholar 

  2. Zbar B, Brauch H, Talmadge C, Linehan M (1987) Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinom. Nature 327: 721–724

    Article  PubMed  CAS  Google Scholar 

ES WL

  1. Eisenberger F, Rassweiler J, Bub P, Kallert B, Miller K (1987) Differentiated approach to staghorn calculi using extracorporeal shockwave lithotripsy and percutaneous nephrolithotomy - an analysis of 151 consecutive cases. World J Urol (in press)

    Google Scholar 

  2. Zwergel, Neisius UD, Zwergel T, Ziegler M (1987) Results and clinical management of the extracorporeal piezoelectric lithotripsy (EPL) in 1321 consecutive treatments. World J Urol 5 (in press)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologischen Universitätsklinik Ulm, Prittwitzstr. 43, D-7900, Ulm, Deutschland

    Prof. Dr. R. Hautmann

Authors
  1. Prof. Dr. R. Hautmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Moorenstr. 5, D-4000, Düsseldorf, Deutschland

    Rolf Ackermann (Direktor der Urologischen Klinik und Poliklinik der Universität Düsseldorf) (Direktor der Urologischen Klinik und Poliklinik der Universität Düsseldorf)

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hautmann, R. (1988). Was gibt’s Neues in der Urologie?. In: Ackermann, R. (eds) Tagung 14.–17. Oktober 1987, Stuttgart. Verhandlungsbericht der Deutschen Gesellschaft für Urologie, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83404-2_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83404-2_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19042-4

  • Online ISBN: 978-3-642-83404-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation